Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 September 2000 | Volume 133 Issue 5 | Pages 329-337
Background: The gene that causes most cases of hereditary hemochromatosis is designated HFE. Three mutations exist at this locus at a relatively high gene frequency.
Objective: To determine the gene frequency of the three HFE mutations and to relate genotypes to various clinical and laboratory variables.
Design: Observational study.
Setting: Health appraisal clinic.
Patients: 10 198 adults who registered for health appraisal and consented to DNA examination for hemochromatosis. Consenting patients were slightly older and had attained a slightly higher educational level than nonconsenting patients.
Measurements: Extensive medical history and laboratory tests, including complete blood count, transferrin saturation, and other chemistries; serum ferritin levels; and HFE genotype.
Results: In white participants, the gene frequencies were 0.063 for the C282Y mutation, 0.152 for the H63D mutation, and 0.016 for the S65C mutation. Gene frequencies were lower in other ethnic groups. In participants with HFE mutations, the average serum transferrin saturation and ferritin levels were slightly increased, as were mean hemoglobin levels and mean corpuscular volume. A transferrin saturation of 50% had a sensitivity of only 0.52 (95% CI, 0.345 to 0.686) and a specificity of 0.908 (CI, 0.902 to 0.914) for detection of homozygosity. A ferritin level of 200 µg/L in women and 250 µg/L in men had a sensitivity of 0.70 (CI, 0.540 to 0.854) and a specificity of 0.803 (CI, 0.796 to 0.811). The prevalence of iron deficiency anemia was lower in women who carried HFE mutations.
Conclusions: Screening for transferrin saturation and ferritin levels does not detect all homozygotes for the major hemochromatosis mutation. Heterozygotes for HFE mutations had a lower prevalence of iron deficiency anemia.
Author and Article Information
From The Scripps Research Institute, La Jolla, California; and Kaiser Permanente, San Diego, California.
Acknowledgments: This report is manuscript number 12824-MEM from The Scripps Research Institute. The authors thank Marsha MacDonald, Renee Olson, Tony Mondala, Priscilla Crisler, Carol West, and Naomi Howard for assistance in performing these investigations.
Grant Support: By grant DK53505-02 supplemented with a grant from the Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, grant RR00833 from the National Institutes of Health, and funds from the Stein Endowment Fund.
Requests for Single Reprints: Ernest Beutler, MD, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; e-mail, beutler{at}scripps.edu.
Requests to Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.
Current Author Addresses: Dr. Beutler, Ms. Gelbart, and Ms. Ho: The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037.
Dr. Fellitti: Kaiser Permanente, 7060 Clairemont Mesa Boulevard, San Diego, CA 92111.
Author Contributions: Conception and design: E. Beutler, V. Felitti.
Analysis and interpretation of the data: E. Beutler, V. Felitti, T. Gelbart, N. Ho.
Drafting of the article: E. Beutler.
Critical revision of the article for important intellectual content: E. Beutler, V. Felitti, T. Gelbart.
Final approval of the article: E. Beutler, V. Felitti, T. Gelbart, N. Ho.
Provision of study materials or patients: V. Felitti.
Statistical expertise: E. Beutler, N. Ho.
Obtaining of funding: E. Beutler.
Administrative, technical, or logistic support: E. Beutler, V. Felitti, T. Gelbart, N. Ho.
Collection and assembly of data: E. Beutler, V. Felitti, T. Gelbart, N. Ho. ARTICLE
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
J. C. Barton Ferritin >1000: grand for hemochromatosis screening? Blood, April 1, 2008; 111(7): 3309 - 3309. [Full Text] [PDF] |
||||
![]() |
J. Waalen, V. J. Felitti, T. Gelbart, and E. Beutler Screening for hemochromatosis by measuring ferritin levels: a more effective approach Blood, April 1, 2008; 111(7): 3373 - 3376. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Harris, C. E. McLaren, D. M. Reboussin, V. R. Gordeuk, J. C. Barton, R. T. Acton, G. D. McLaren, T. M. Vogt, B. M. Snively, C. Leiendecker-Foster, et al. Serum Ferritin and Transferrin Saturation in Asians and Pacific Islanders Arch Intern Med, April 9, 2007; 167(7): 722 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ellervik, A. Tybjaerg-Hansen, M. Appleyard, H. Sillesen, G. Boysen, and B. G. Nordestgaard Hereditary hemochromatosis genotypes and risk of ischemic stroke Neurology, March 27, 2007; 68(13): 1025 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Park, M. S. O'Neill, R. O. Wright, H. Hu, P. S. Vokonas, D. Sparrow, H. Suh, and J. Schwartz HFE Genotype, Particulate Air Pollution, and Heart Rate Variability: A Gene-Environment Interaction Circulation, December 19, 2006; 114(25): 2798 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Lehmann, M Worwood, R Ellis, V L J Wimhurst, A T Merryweather-Clarke, D R Warden, A D Smith, and K J H Robson Iron genes, iron load and risk of Alzheimer's disease. J. Med. Genet., October 1, 2006; 43(10): e52 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Whitlock, B. A. Garlitz, E. L. Harris, T. L. Beil, and P. R. Smith Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, August 1, 2006; 145(3): 209 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Beutler and C. West Hematologic differences between African-Americans and whites: the roles of iron deficiency and {alpha}-thalassemia on hemoglobin levels and mean corpuscular volume Blood, July 15, 2005; 106(2): 740 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ellervik, A. Tybjaerg-Hansen, P. Grande, M. Appleyard, and B. G. Nordestgaard Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study Circulation, July 12, 2005; 112(2): 185 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, and C. S. Fuchs Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women J Natl Cancer Inst, June 15, 2005; 97(12): 917 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Roe, A.-L. M Heath, S. L Oyston, C. Macrow, J. A Hoogewerff, R. Foxall, J. R Dainty, G. Majsak-Newman, G. Willis, and S. J Fairweather-Tait Iron absorption in male C282Y heterozygotes Am. J. Clinical Nutrition, April 1, 2005; 81(4): 814 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McGlynn, L. C. Sakoda, Y. Hu, R. E. Schoen, R. S. Bresalier, M. Yeager, S. Chanock, R. B. Hayes, and K. H. Buetow Hemochromatosis Gene Mutations and Distal Adenomatous Colorectal Polyps Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 158 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Guralnik, W. B. Ershler, S. L. Schrier, and V. J. Picozzi Anemia in the Elderly: A Public Health Crisis in Hematology Hematology, January 1, 2005; 2005(1): 528 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Hunt and H. Zeng Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis Am. J. Clinical Nutrition, October 1, 2004; 80(4): 924 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Andersen, A. Tybjaerg-Hansen, M. Appleyard, H. Birgens, and B. G. Nordestgaard Hemochromatosis mutations in the general population: iron overload progression rate Blood, April 15, 2004; 103(8): 2914 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. McLaren, K.-T. Li, C. P. Garner, E. Beutler, and V. R. Gordeuk Mixture distribution analysis of phenotypic markers reflecting HFE gene mutations Blood, December 15, 2003; 102(13): 4563 - 4566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. McDonnell and R. G. Parrish Hereditary Hemochromatosis and Its Elusive Natural History Arch Intern Med, November 10, 2003; 163(20): 2421 - 2423. [Full Text] [PDF] |
||||
![]() |
S. Dubois and K. V. Kowdley The Importance of Screening for Hemochromatosis Arch Intern Med, November 10, 2003; 163(20): 2424 - 2426. [Full Text] [PDF] |
||||
![]() |
N. Wohllk, R. Zapata, M. Acuna, H. Reyes, A. Navarro, I. Roa, and J. C. Roa HFE Gene Mutations in Chile Ann Intern Med, October 21, 2003; 139(8): 708 - 709. [Full Text] [PDF] |
||||
![]() |
S Campbell, D K George, S D Robb, R Spooner, T A McDonagh, H J Dargie, and P R Mills The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease Heart, September 1, 2003; 89(9): 1023 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Killeen, J. W. Breneman III, A. R. Carillo, J. Liu, and C. S. Hixson Linked Linear Amplification for Simultaneous Analysis of the Two Most Common Hemochromatosis Mutations Clin. Chem., July 1, 2003; 49(7): 1050 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Shaheen, L. M. Silverman, T. Keku, L. B. Lawrence, E. M. Rohlfs, C. F. Martin, J. Galanko, and R. S. Sandler Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer J Natl Cancer Inst, January 15, 2003; 95(2): 154 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Beutler, T. Gelbart, and P. Lee Haptoglobin Polymorphism and Iron Homeostasis Clin. Chem., December 1, 2002; 48(12): 2232 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Holmstrom, J Marmur, G Eggertsen, M Gafvels, and P Stal Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls Gut, November 1, 2002; 51(5): 723 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Correction: The Effect of HFE Genotypes on Measurements of Iron Overload Ann Intern Med, October 15, 2002; 137(8): 705 - 705. [Full Text] [PDF] |
||||
![]() |
J. A. Koziol, V. J. Felitti, and E. Beutler The Effect of HFE Genotypes on Measurements of Iron Overload Ann Intern Med, October 15, 2002; 137(8): 700 - 701. [Full Text] [PDF] |
||||
![]() |
D Trinder, C Fox, G Vautier, and J K Olynyk Molecular pathogenesis of iron overload Gut, August 1, 2002; 51(2): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mattman, D. Huntsman, G. Lockitch, S. Langlois, N. Buskard, D. Ralston, Y. Butterfield, P. Rodrigues, S. Jones, G. Porto, et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation Blood, July 18, 2002; 100(3): 1075 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Beutler and V. J. Felitti The C282Y Mutation Does Not Shorten Life Span Arch Intern Med, May 27, 2002; 162(10): 1196 - 1197. [Full Text] [PDF] |
||||
![]() |
V. Herbert Hereditary Hemochromatosis Ann Intern Med, December 18, 2001; 135(12): 1091 - 1091. [Full Text] [PDF] |
||||
![]() |
C. E. McLaren, K.-T. Li, V. R. Gordeuk, V. Hasselblad, and G. D. McLaren Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey Blood, October 15, 2001; 98(8): 2345 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Koziol, N. J. Ho, V. J. Felitti, and E. Beutler Reference Centiles for Serum Ferritin and Percentage of Transferrin Saturation, with Application to Mutations of the HFE Gene Clin. Chem., October 1, 2001; 47(10): 1804 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lyon and E. L. Frank Hereditary Hemochromatosis Since Discovery of the HFE Gene Clin. Chem., July 1, 2001; 47(7): 1147 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
P C ADAMS Iron overload in Montpelier Gut, June 1, 2001; 48(6): 755 - 756. [Full Text] [PDF] |
||||
![]() |
K. K. Steinberg, M. E. Cogswell, J. C. Chang, S. P. Caudill, G. M. McQuillan, B. A. Bowman, L. M. Grummer-Strawn, E. J. Sampson, M. J. Khoury, and M. L. Gallagher Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United States JAMA, May 2, 2001; 285(17): 2216 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Evans, C. Skrzynia, and W. Burke The complexities of predictive genetic testing BMJ, April 28, 2001; 322(7293): 1052 - 1056. [Full Text] |
||||
![]() |
R. E. Fleming, C. C. Holden, S. Tomatsu, A. Waheed, E. M. Brunt, R. S. Britton, B. R. Bacon, D. C. Roopenian, and W. S. Sly Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis PNAS, February 27, 2001; 98(5): 2707 - 2711. [Abstract] [Full Text] [PDF] |
||||
![]() |
Screening for Hemochromatosis: More Questions than Answers Journal Watch (General), September 19, 2000; 2000(919): 1 - 1. [Full Text] |
||||
![]() |
T. J. Sproule, E. C. Jazwinska, R. S. Britton, B. R. Bacon, R. E. Fleming, W. S. Sly, and D. C. Roopenian Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice PNAS, April 24, 2001; 98(9): 5170 - 5174. [Abstract] [Full Text] [PDF] |
||||